Palliative chemotherapy in non-small cell lung cancer (NSCLC): first-line therapy data from the ACTION observational study Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
Palliative chemotherapy in non-small cell lung cancer (NSCLC): analysis of UK baseline data from the ACTION observational study Source: Eur Respir J 2005; 26: Suppl. 49, 11s Year: 2005
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care. Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Real-life effectiveness of first-line treatments in NSCLC patients stage IIIB/IV– data from the Czech TULUNG Registry. Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020
The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting Source: Eur Respir J 2002; 20: Suppl. 38, 399s Year: 2002
The efficacy and safety of induction chemoradiotherapy (ICRT) followed by surgery in stage III NSCLC patients (pts) with T3/4-adjacent organ invasion involved(AOI): A single-center retrospective observational study. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonrandomized population of 259 patients Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
Quality of life in patients with advanced NSCLC submited to chemotherapy Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
A three-arm phase III randomised trial assessing, in patients with extensive-disease (ED) small-cell lung cancer (SCLC), accelerated chemotherapy with the support of haematological growth factor or of oral antibiotics Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001
Impact of early weight loss during concurrent chemoradiotherapy on survival in advanced stage NSCLC patients Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Study of patient nominated symptoms and changing symptamatology in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
Determinants of completion of a home-based rehabilitation program in patients awaiting lung surgery for lung cancer : a prospective observational multicenter study Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020
Quality of life assessment in advanced stage of lung cancer patients before and after chemotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): the MRC LU22/NVALT/EORTC 08012 multi-centre randomised trial Source: Eur Respir J 2007; 30: Suppl. 51, 240s Year: 2007
Phase II study of S-1 with patient-reported outcome evaluation in elderly patients with previously untreated advanced non-small cell lung cancer Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Efficacy and safety of nivolumab in routine NSCLC treatment – an observational study in 5 lung cancer centers in Berlin, Germany Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Short-time exercise-induced rehabilitation in non-small cell lung cancer patients during in-hospital chemotherapy treatment: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Observations on quality of life assessments using functional assessment of cancer-Lung (FACT-L) in patients under lung cancer chemotherapy. Ongoing study Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Quality of life analysis in patients with NSCLC before and after chemotherapy Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
External comparison of hospitals concerning quality of oncological care of patients with lung cancer in an outcome evaluation study from a population-based regional cancer registry Source: Eur Respir J 2001; 18: Suppl. 33, 438s Year: 2001